PR Newswire
ST. LOUIS, April 26, 2024
-- Diluted EPS of $2.16; Adjusted Diluted EPS of $2.26 --
-- Increases 2024 Full Year Guidance --
ST. LOUIS, April 26, 2024 /PRNewswire/ -- Centene Corporation (NYSE: CNC) ("the Company") announced today its financial results for the first quarter ended March 31, 2024. In summary, the 2024 first quarter results were as follows:
Total revenues (in millions) | $ 40,407 | | |||||||||||
Premium and service revenues (in millions) | $ 36,337 | | |||||||||||
Health benefits ratio ARIVA.DE Börsen-GeflüsterWerbung Weiter aufwärts?
Vontobel
Den Basisprospekt sowie die Endgültigen Bedingungen und die Basisinformationsblätter erhalten Sie hier: VM55LW,. Beachten Sie auch die weiteren Hinweise zu dieser Werbung. Der Emittent ist berechtigt, Wertpapiere mit open end-Laufzeit zu kündigen.
Kurse | 87.1 % | | |||||||||||
SG&A expense ratio | 8.9 % | | |||||||||||
Adjusted SG&A expense ratio (1) | 8.7 % | | |||||||||||
GAAP diluted EPS | $ 2.16 | | |||||||||||
Adjusted diluted EPS (1) | $ 2.26 | | |||||||||||
Total cash flow used in operations (in millions) | $ (456) | | |||||||||||
| | | |
| | ||
(1) | Represents a non-GAAP financial measure. A full reconciliation of the adjusted diluted earnings per share (EPS) and adjusted selling, general and administrative (SG&A) expenses is shown in the Non-GAAP Financial Presentation section of this release. |
"Centene's first quarter results demonstrate the strength of our diversified platform. We are pleased to raise full year 2024 guidance as we look to maximize the positive momentum being generated by our core businesses. We are executing against our strategic plans for growth and increasing access to affordable, high-quality healthcare for our members and the communities we serve," said Chief Executive Officer of Centene, Sarah M. London.
Other Events
Awards & Community Engagement
Membership
The following table sets forth membership by line of business:
| March 31, | |||
| 2024 | | 2023 | |
Traditional Medicaid (1) | 11,750,000 | | 14,521,100 | |
High Acuity Medicaid (2) | 1,547,600 | | 1,801,200 | |
Total Medicaid | 13,297,600 | | 16,322,300 | |
Commercial Marketplace | 4,348,800 | | 3,093,600 | |
Commercial Group | 422,700 | | 437,200 | |
Total Commercial | 4,771,500 | | 3,530,800 | |
Medicare (3) | 1,146,800 | | 1,343,800 | |
Medicare PDP | 6,438,900 | | 4,459,300 | |
Total at-risk membership | 25,654,800 | | 25,656,200 | |
TRICARE eligibles | 2,768,000 | | 2,799,300 | |
Total | 28,422,800 | | 28,455,500 | |
| | | | |
| | |||
(1) | Membership includes Temporary Assistance for Needy Families (TANF), Medicaid Expansion, Children's Health Insurance | |||
(2) | Membership includes Aged, Blind, or Disabled (ABD), Intellectual and Developmental Disabilities (IDD), Long-Term | |||
(3) | Membership includes Medicare Advantage and Medicare Supplement. |
Premium and Service Revenues
The following table sets forth supplemental revenue information ($ in millions):
| | Three Months Ended March 31, | ||||
| | 2024 | | 2023 | | % Change |
Medicaid | $ 21,460 | | $ 22,227 | | (3) % | |
Commercial | 7,751 | | 5,252 | | 48 % | |
Medicare (1) | 5,935 | | 5,876 | | 1 % | |
Other | 1,191 | | 1,597 | | (25) % | |
Total premium and service revenues | $ 36,337 | | $ 34,952 | | 4 % | |
| | | | | | |
| | |||||
(1) | Medicare includes Medicare Advantage, Medicare Supplement, D-SNPs and Medicare Prescription Drug Plan (PDP). |
Statement of Operations: Three Months Ended March 31, 2024
Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.